The Comparison of the Efficacy of Baloxavir and Neuraminidase Inhibitors for Patients with Influenza A in Clinical Practice

OBJECTIVE: Baloxavir marboxil is a novel anti-influenza drug reported to have an early antiviral effect, although it also causes the appearance of variant viruses with a reduced susceptibility to baloxavir. In Japan, four neuraminidase inhibitors (NAIs) have been commonly used to treat patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshii, Naoko, Tochino, Yoshihiro, Fujioka, Masashi, Sakazaki, Hiromi, Maruyama, Naomi, Asai, Kazuhisa, Kakeya, Hiroshi, Shintaku, Haruo, Kawaguchi, Tomoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364256/
https://www.ncbi.nlm.nih.gov/pubmed/32536677
http://dx.doi.org/10.2169/internalmedicine.4117-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364256/
https://www.ncbi.nlm.nih.gov/pubmed/32536677
http://dx.doi.org/10.2169/internalmedicine.4117-19

Ejemplares similares